Insider Transactions in Q4 2025 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2025
|
Matthew L. Kaplan Director |
BUY
Open market or private purchase
|
Direct |
11,000
+8.1%
|
$55,000
$5.84 P/Share
|
|
Nov 05
2025
|
Juan Sanchez Director |
BUY
Open market or private purchase
|
Direct |
13,000
+14.26%
|
$65,000
$5.79 P/Share
|
|
Nov 05
2025
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.14%
|
$25,000
$5.72 P/Share
|
|
Oct 27
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
72,836
+2.27%
|
$437,016
$6.28 P/Share
|
|
Oct 24
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
35,034
+1.13%
|
$210,204
$6.15 P/Share
|
|
Oct 23
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,900
+1.52%
|
$281,400
$6.06 P/Share
|